免疫介导的结肠炎：用于治疗多发性硬化症的抗CD20药物的类效应？ - Suppr | 超能文献

Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?

作者信息

Viti Vittorio, Zanetta Chiara, Rocca Maria A, Filippi Massimo

机构信息

Neurology Unit and Multiple Sclerosis Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Mult Scler. 2025 Feb;31(2):245-246. doi: 10.1177/13524585241303480. Epub 2024 Dec 7.

DOI:10.1177/13524585241303480

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?免疫介导的结肠炎：用于治疗多发性硬化症的抗CD20药物的类效应？

Mult Scler. 2025 Feb;31(2):245-246. doi: 10.1177/13524585241303480. Epub 2024 Dec 7.

2

Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease.

Gastroenterology. 2003 Feb;124(2):583. doi: 10.1053/gast.2003.50081.

3

A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis.一种植物细胞表达的重组抗TNF融合蛋白在肠道中具有生物活性，可减轻免疫介导的肝炎和结肠炎。

Immunobiology. 2017 Mar;222(3):544-551. doi: 10.1016/j.imbio.2016.11.001. Epub 2016 Nov 4.

4

Identification of formaldehyde-induced modifications in proteins: reactions with insulin.蛋白质中甲醛诱导修饰的鉴定：与胰岛素的反应

Bioconjug Chem. 2006 May-Jun;17(3):815-22. doi: 10.1021/bc050340f.

5

Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.考帕松对实验性结肠炎的改善作用与II类分子限制性CD4免疫阻断有关。

Clin Immunol. 2006 Feb-Mar;118(2-3):307-16. doi: 10.1016/j.clim.2005.10.004. Epub 2005 Nov 14.

6

The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor.使用二甲双胍、免疫介导性结肠炎与接受检查点抑制剂治疗患者的总生存率之间的关联。

Eur J Cancer. 2025 May 15;221:115405. doi: 10.1016/j.ejca.2025.115405. Epub 2025 Apr 2.

7

Colitis associated with biological agents.与生物制剂相关的结肠炎。

World J Gastroenterol. 2012 Apr 28;18(16):1871-4. doi: 10.3748/wjg.v18.i16.1871.

8

Ofatumumab-associated colitis: A case report.

Mult Scler. 2025 Feb;31(2):242-245. doi: 10.1177/13524585241303479. Epub 2024 Dec 7.

9

Investigation of the material basis and mechanism of Lizhong decoction in ameliorating ulcerative colitis based on spectrum-effect relationship and network pharmacology.基于谱效关系和网络药理学探讨理中汤改善溃疡性结肠炎的物质基础和作用机制。

J Ethnopharmacol. 2024 Apr 6;323:117666. doi: 10.1016/j.jep.2023.117666. Epub 2023 Dec 28.

10

Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.抗炎生物制剂和抗肿瘤免疫疗法相关的结肠炎：文献综述

Gastroenterology Res. 2018 Jun;11(3):174-188. doi: 10.14740/gr1041w. Epub 2018 May 31.

引用本文的文献

1

Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients.奥瑞珠单抗诱导的结肠炎——来自罗马尼亚多发性硬化症患者队列的批判性综述与病例系列

Front Neurol. 2025 Feb 5;16:1530438. doi: 10.3389/fneur.2025.1530438. eCollection 2025.